Quick Facts
What Is Abilify?
Aripiprazole (brand name Abilify) is a second-generation (atypical) antipsychotic (SGA) prescribed for trd augmentation, schizophrenia, bipolar disorder, and other psychiatric conditions. Only partial dopamine agonist antipsychotic (3rd generation). Lower metabolic risk than most SGAs. FDA-approved for TRD augmentation. Available as monthly long-acting injectable (Abilify Maintena). Activating rather than sedating.
At Psychiatry Telemed, aripiprazole is prescribed and monitored by board-certified psychiatrists who understand the nuances of SGA pharmacology — selecting the right dose, managing side effects, monitoring drug interactions, and optimizing your treatment through consistent monthly medication management appointments.
Aripiprazole (Abilify) — SGA medication for psychiatric care
How Abilify Affects Neurotransmitters
How Abilify Works
Aripiprazole is a partial dopamine D2 agonist — it modulates dopamine rather than simply blocking it. In hyperdopaminergic states (psychosis), it acts as a functional antagonist. In hypodopaminergic states (negative symptoms, depression), it acts as a functional agonist. This dual action produces antipsychotic effects with less metabolic disruption.
Efficacy: Abilify vs. Comparators
Efficacy Comparison
Response & remission rates vs. comparators (Cipriani et al. meta-analysis)
Data from published meta-analyses. Individual response may vary.
Conditions Treated with Abilify
TRD Augmentation
FDA-approved to augment antidepressants in treatment-resistant depression (2–15mg).
Learn About TRD AugmentationSchizophrenia
FDA-approved. Unique partial dopamine agonist mechanism with favorable metabolic profile.
Learn About SchizophreniaConsidering Abilify?
Board-certified psychiatrists can determine if aripiprazole is right for you.
Dosage Information
| Indication | Starting Dose | Typical Range | Maximum |
|---|---|---|---|
| TRD Augmentation | 2–5mg/day | 5–30mg/day | 30mg/day |
| Schizophrenia | 2–5mg/day | 5–30mg/day | 30mg/day |
| Bipolar Disorder | 2–5mg/day | 5–30mg/day | 30mg/day |
| OCD Augmentation | 2–5mg/day | 5–30mg/day | 30mg/day |
Brain Regions Targeted by Abilify
Side Effects
Like all medications, aripiprazole has potential side effects. Most are mild, occur early in treatment, and resolve within 1–2 weeks. Your psychiatrist monitors at every appointment.
Common Side Effects
Less Common
Serious (Seek Immediate Help)
Side Effect Profile: Abilify vs. Class Average
Side Effect Profile
Incidence rates from FDA prescribing information vs. class average
Percentages from clinical trial data. Actual experience may differ.
⚠️ FDA Black Box Warning
Antidepressants may increase suicidal thinking in young adults under 25.
Drug Interactions
Major Interactions
CNS depressants (additive sedation), CYP inhibitors/inducers (varies by drug), QTc-prolonging agents
CYP Metabolism
Substrate of CYP2D6, CYP3A4. Consult drug interaction database for specific combinations.
Alcohol
Avoid alcohol during aripiprazole treatment. Both affect the CNS, increasing sedation and impairing judgment.
Generic Versions & Cost
Generic aripiprazole available since 2015. Approximate cost: $10–25/month. FDA-certified bioequivalent to brand-name Abilify.
Starting Abilify: What to Expect
First Weeks
Aripiprazole is typically started at 2–5mg/day and increased gradually. Common initial side effects usually improve within 1–2 weeks. Full therapeutic benefit develops over 4–8 weeks.
When to Contact Your Psychiatrist
Contact your psychiatrist for: worsening depression/anxiety, thoughts of self-harm, unusual agitation, severe side effects, or any concerning changes.
Stopping Abilify Safely
Never stop aripiprazole abruptly. Your psychiatrist will develop a gradual tapering schedule to minimize discontinuation effects.
Timeline: When Abilify Starts Working
Timeline to Effectiveness
Expected improvement trajectory over the first 8 weeks
Based on clinical trial data. Full therapeutic effects may take 6–8 weeks.
Get Abilify from a Board-Certified Psychiatrist
At Psychiatry Telemed, aripiprazole is prescribed following comprehensive evaluation. All Florida via HIPAA-compliant telepsychiatry. 1–3 days. $200 eval, $100 follow-up.
Frequently Asked Questions
Prescribed for trd augmentation, schizophrenia, bipolar disorder, ocd augmentation.
Typically 2–4 weeks for initial improvement, 4–8 weeks for full benefit.
Common: weight gain, drowsiness/sedation, dizziness, metabolic effects, akathisia. Most resolve within 1–2 weeks.
No. Not habit-forming but should not be stopped abruptly — gradual tapering recommended.
Only partial dopamine agonist antipsychotic (3rd generation). Lower metabolic risk than most SGAs. FDA-approved for TRD augmentation. Available as monthly long-acting injectable (Abilify Maintena). Ac
Alcohol should be avoided — increases sedation, impairs judgment, and may worsen symptoms.
Resources
Medical Disclaimer: Educational only. Consult a psychiatrist before starting/stopping medication. Crisis: call 988 or 911.
Last reviewed: